These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26089157)

  • 1. Circulating Endothelial Progenitor Cell Levels Predict Cardiovascular Events in End-Stage Renal Disease Patients on Maintenance Hemodialysis.
    Lee HJ; Kim W; Kim WS; Woo JS; Kim YG; Moon JY; Lee SH; Ihm CG; Lee TW; Jeong KH
    Nephron; 2015; 130(3):151-8. PubMed ID: 26089157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of circulating progenitor cells associated with vascular thrombosis of hemodialysis patients.
    Hsieh MY; Chen TY; Lin L; Chuang SY; Lin SJ; Tarng DC; Huang PH; Wu CC
    Nephrol Dial Transplant; 2017 Mar; 32(3):556-564. PubMed ID: 28339557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial Progenitor Cells Predict Long-Term Mortality in Hemodialysis Patients.
    Lu CL; Leu JG; Liu WC; Zheng CM; Lin YF; Shyu JF; Wu CC; Lu KC
    Int J Med Sci; 2016; 13(3):240-7. PubMed ID: 26941585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysis modality is independently associated with circulating endothelial progenitor cells in end-stage renal disease patients.
    Ueno H; Koyama H; Fukumoto S; Tanaka S; Shoji T; Shoji T; Emoto M; Tahara H; Tsujimoto Y; Tabata T; Nishizawa Y
    Nephrol Dial Transplant; 2010 Feb; 25(2):581-6. PubMed ID: 19628645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red cell distribution width is associated with endothelial progenitor cell depletion and vascular-related mediators in rheumatoid arthritis.
    Rodríguez-Carrio J; Alperi-López M; López P; Alonso-Castro S; Carro-Esteban SR; Ballina-García FJ; Suárez A
    Atherosclerosis; 2015 May; 240(1):131-6. PubMed ID: 25778627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis.
    Herbrig K; Pistrosch F; Oelschlaegel U; Wichmann G; Wagner A; Foerster S; Richter S; Gross P; Passauer J
    Am J Kidney Dis; 2004 Nov; 44(5):840-9. PubMed ID: 15492950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of endothelial progenitor cell (CD34) as a marker of cardiovascular risk in children on regular hemodialysis.
    Abdel-Salam M; Abd Elsalam R; Youssef N; Mamdouh F; Abdel-Salam T
    Saudi J Kidney Dis Transpl; 2018; 29(4):785-792. PubMed ID: 30152413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study.
    Amabile N; Guérin AP; Tedgui A; Boulanger CM; London GM
    Nephrol Dial Transplant; 2012 May; 27(5):1873-80. PubMed ID: 22036944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair.
    Schmidt-Lucke C; Rössig L; Fichtlscherer S; Vasa M; Britten M; Kämper U; Dimmeler S; Zeiher AM
    Circulation; 2005 Jun; 111(22):2981-7. PubMed ID: 15927972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial progenitor cells as a biological marker of peripheral artery disease.
    Bitterli L; Afan S; Bühler S; DiSanto S; Zwahlen M; Schmidlin K; Yang Z; Baumgartner I; Diehm N; Kalka C
    Vasc Med; 2016 Feb; 21(1):3-11. PubMed ID: 26511986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum levels of fractalkine and mobilisation of CD34
    Benyamine A; Magalon J; Cointe S; Lacroix R; Arnaud L; Bardin N; Rossi P; Francès Y; Bernard-Guervilly F; Kaplanski G; Harlé JR; Weiller PJ; Berbis P; Braunstein D; Jouve E; Lesavre N; Couranjou F; Dignat-George F; Sabatier F; Paul P; Granel B
    Arthritis Res Ther; 2017 Mar; 19(1):60. PubMed ID: 28320472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent hypermulticolor monitoring of CD31, CD34, CD45 and CD146 endothelial progenitor cell markers for acute myocardial infarction.
    Shim Y; Nam MH; Hyuk SW; Yoon SY; Song JM
    Anal Chim Acta; 2015 Jan; 853():501-507. PubMed ID: 25467496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of endothelial progenitor cells on restenosis after percutaneous angioplasty of hemodialysis vascular access.
    Wu CC; Huang PH; Lai CL; Leu HB; Chen JW; Lin SJ
    PLoS One; 2014; 9(6):e101058. PubMed ID: 24964143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus.
    Yue WS; Lau KK; Siu CW; Wang M; Yan GH; Yiu KH; Tse HF
    Cardiovasc Diabetol; 2011 Dec; 10():113. PubMed ID: 22185563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidimensional Proteomic Approach of Endothelial Progenitors Demonstrate Expression of KDR Restricted to CD19 Cells.
    Guerin CL; Guyonnet L; Goudot G; Revets D; Konstantinou M; Chipont A; Chocron R; Blandinieres A; Khider L; Rancic J; Peronino C; Debuc B; Cras A; Knosp C; Latremouille C; Capel A; Ollert M; Diehl JL; Jansen P; Planquette B; Sanchez O; Gaussem P; Mirault T; Carpentier A; Gendron N; Smadja DM
    Stem Cell Rev Rep; 2021 Apr; 17(2):639-651. PubMed ID: 33205351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous PCSK9 may influence circulating CD45
    Tripaldi R; Lanuti P; Simeone PG; Liani R; Bologna G; Ciotti S; Simeone P; Di Castelnuovo A; Marchisio M; Cipollone F; Santilli F
    Sci Rep; 2021 May; 11(1):9659. PubMed ID: 33958634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of Circulating Progenitor Cells, Cardiovascular Outcomes and Death: A Meta-Analysis of Prospective Observational Studies.
    Rigato M; Avogaro A; Fadini GP
    Circ Res; 2016 Jun; 118(12):1930-9. PubMed ID: 27073015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of low circulating endothelial progenitor cell numbers in haemodialysis patients.
    Schlieper G; Hristov M; Brandenburg V; Krüger T; Westenfeld R; Mahnken AH; Yagmur E; Boecker G; Heussen N; Gladziwa U; Ketteler M; Weber C; Floege J
    Nephrol Dial Transplant; 2008 Aug; 23(8):2611-8. PubMed ID: 18353889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Endothelial Progenitor Cells and Clinical Outcome in Patients with Aortic Stenosis.
    Shimoni S; Bar I; Meledin V; Derazne E; Gandelman G; George J
    PLoS One; 2016; 11(2):e0148766. PubMed ID: 26913741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients.
    Golab-Janowska M; Paczkowska E; Machalinski B; Kotlega D; Meller A; Safranow K; Wankowicz P; Nowacki P
    Curr Neurovasc Res; 2019; 16(1):19-26. PubMed ID: 30706812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.